Jordain Hardin
Family · West Jefferson, NCNPI 1447810577
Payments from drug & device makers
Across 207 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$474
- AbbVie$448
- Corium, LLC$252
- Paragon 28, Inc.$229
- Novo Nordisk$198
- Novartis$198
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,641100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 35 | $474 |
| AbbVie | 32 | $448 |
| Corium, LLC | 13 | $252 |
| Paragon 28, Inc. | 2 | $229 |
| Novo Nordisk | 11 | $198 |
| Novartis | 13 | $198 |
| Pfizer | 4 | $157 |
| Phathom Pharmaceuticals, Inc. | 4 | $139 |
| Bausch Health US, LLC | 8 | $138 |
| Boehringer Ingelheim | 9 | $128 |
| GSK | 7 | $119 |
| AstraZeneca | 8 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $108 |
| Lilly USA, LLC | 6 | $95 |
| Dexcom, Inc. | 3 | $91 |
| Exact Sciences | 5 | $89 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $87 |
| Bayer | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Organon | 3 | $41 |
| Insulet Corporation | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Alkermes, Inc. | 1 | $24 |
| Viatris Specialty LLC | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Tolmar, Inc. | 1 | $14 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$124
- GORILLA ANKLE FX$105
How this compares
$3,641 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 29 | $30,433 |
| MounjaroTirzepatide | 17 | $24,469 |
| Repatha SureclickEvolocumab | 14 | $18,519 |
| TrulicityDulaglutide | 14 | $11,809 |
| TradjentaLinagliptin | 19 | $11,465 |
| EliquisApixaban | 12 | $11,117 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $6,564 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $4,273 |
| Novolog FlexpenInsulin Aspart | 15 | $2,010 |
| SynthroidLevothyroxine Sodium | 20 | $1,919 |
| ValacyclovirValacyclovir Hcl | 12 | $1,632 |
| Celecoxib | 34 | $1,363 |
| Gabapentin | 96 | $1,297 |
| Omeprazole | 85 | $993 |
| Levothyroxine Sodium | 109 | $925 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $128 | $41,89848 claims |
| Lilly USA, LLCMounjaro, Trulicity | $95 | $36,27831 claims |
| PfizerEliquis | $157 | $11,11712 claims |
| AbbVieSynthroid | $448 | $1,91920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in West Jefferson
- Derek McClureWest Jefferson$14K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.